These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2854575)

  • 1. [Posttransfusion cytomegalovirus infection].
    Mori T
    Rinsho Byori; 1988 Sep; 36(9):1032-7. PubMed ID: 2854575
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
    Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
    Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation.
    Elfenbein G; Krischer J; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3099-100. PubMed ID: 2539688
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfusion-transmitted cytomegalovirus infection.
    Bowden RA
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):155-66. PubMed ID: 7737939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
    Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
    Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transmission cytomegalovirus infection by blood transfusions].
    Mañez R
    Sangre (Barc); 1993 Jun; 38(3):201-4. PubMed ID: 8211545
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary cytomegalovirus infection and its prevention after autologous bone marrow transplantation.
    Verdonck LF; Middeldorp JM; Kreeft HA; The TH; Hekker A; de Gast GC
    Transplantation; 1985 Apr; 39(4):455-7. PubMed ID: 2984811
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic use of ganciclovir for allogeneic bone marrow transplant recipients.
    von Bueltzingsloewen A; Bordigoni P; Witz F; Bene MC; Schmitt C; Lacour B; Sommelet D
    Bone Marrow Transplant; 1993 Sep; 12(3):197-202. PubMed ID: 8241976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytomegalovirus infection after transfusion].
    Kai S; Hara H
    Rinsho Byori; 1991 Mar; Suppl 88():176-82. PubMed ID: 1649928
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytomegalovirus infections following transplantation: diagnosis, prevention and treatment].
    Calain P; Lew D
    Rev Med Suisse Romande; 1988 Aug; 108(8):697-701. PubMed ID: 2847275
    [No Abstract]   [Full Text] [Related]  

  • 12. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study.
    Narvios AB; Lichtiger B
    Haematologica; 2001 Jul; 86(7):749-52. PubMed ID: 11454531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMV and blood transfusions.
    Roback JD
    Rev Med Virol; 2002; 12(4):211-9. PubMed ID: 12125013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
    Winston DJ; Ho WG; Bartoni K; Champlin RE
    Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxoplasmic and cytomegalic infections. (Risk factors in blood transfusion practice)].
    Moiraghi Ruggenini A; Zotti C; Zappia F; Bruno L
    Ric Clin Lab; 1979; 9(2 Suppl):65-72. PubMed ID: 231813
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interstitial pneumonia in leukemia patients after allogeneic bone marrow transplantation].
    Yamauchi T; Miyamura K; Nomura S; Minami S; Yoshikawa H; Sakai S; Yoshikawa S; Kodera Y; Sao H; Tahara T
    Rinsho Ketsueki; 1986 Aug; 27(8):1361-8. PubMed ID: 3025473
    [No Abstract]   [Full Text] [Related]  

  • 18. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
    Funada H; Harada M; Yoshida T; Hattori K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic use of immunoglobulin in bone marrow transplantation.
    Ho WG; Winston DJ; Champlin RE; Gale RP
    Int J Cell Cloning; 1986; 4 Suppl 1():174-80. PubMed ID: 3018101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.